Google, acting through its life-science subsidiary Verily, plans to release tens of millions of sterile or Wolbachia-infected mosquitoes in the U.S. [1].

This initiative represents a large-scale biological intervention to suppress populations of insects that carry dangerous pathogens. By introducing mosquitoes that cannot produce viable offspring or are unable to transmit viruses, the company seeks to break the cycle of infection in high-risk regions.

The program targets the reduction of mosquito-borne illnesses, including dengue, and the West Nile virus [1, 4]. According to reports, the release of these insects would take place over a period of up to two years [2].

There are varying accounts regarding the scale of the operation. One report indicates the plan involves up to 32 million mosquitoes [2], while another suggests the number could reach 64 million [4]. The primary geographic focus is the state of Florida, though some reports include California in the scope of the release [2, 3].

Verily utilizes two primary methods for population control. One involves the release of sterile mosquitoes to prevent reproduction. The other utilizes the Wolbachia bacterium, which can inhibit the ability of mosquitoes to transmit diseases to humans [1, 4].

The Centers for Disease Control and Prevention said the approach is safe [1]. The company has applied to the U.S. Environmental Protection Agency to proceed with the deployment of these insects across the targeted areas.

“Google, acting through its life-science subsidiary Verily, plans to release tens of millions of sterile or Wolbachia-infected mosquitoes in the U.S.”

This project marks a significant expansion of private-sector involvement in public health infrastructure. By leveraging biological control methods rather than chemical pesticides, Google is testing a scalable model for disease prevention that could be exported to other tropical regions globally if successful in the U.S.